Loading…
4 companies · GEL, thousands · columns ordered by revenue
Only 2 of 4 peers filed FY2024. Switch to FY2023 (3 of 4).
| Line item | Aptos | Sakartvelos Etlebis Sat… | New Technology Impex | Doktor Gudsi |
|---|---|---|---|---|
| Total Revenue | 64,936 | 2,292 | — | — |
| Total COGS | -27,885 | -992 | — | — |
| Gross Profit | 37,051 | 1,300 | — | — |
| Gross Margin | 57.1% | 56.7% | — | — |
| Other Operating Income | 367 | — | — | — |
| Total Operating Expenses | -39,933 | -836 | — | — |
| EBITDA | -2,515 | 464 | — | — |
| EBITDA Margin | -3.9% | 20.3% | — | — |
| Total D&A | -2,265 | -180 | — | — |
| EBIT / Operating Income | -4,780 | 285 | — | — |
| Total Interest Income | 76 | — | — | — |
| Total Interest Expense | -623 | -69 | — | — |
| Total Other Income | 81 | -6 | — | — |
| Profit Before Tax | -5,246 | 210 | — | — |
| Total Income Tax | -332 | 0 | — | — |
| Net Profit / (Loss) | -5,917 | 210 | — | — |
| Net Margin | -9.1% | 9.1% | — | — |
| Other Comprehensive Income | -73 | — | — | — |
| Total Comprehensive Income | -5,990 | — | — | — |
Not every picked company reports every selected year — FY2024: no filing for New Technology Impex and Doktor Gudsi. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Sakartvelos Etlebis Sat… | Medical Devices | 20.3% | 77th pct | 39 |
| Aptos | Medical Devices | -3.9% | 10th pct | 39 |
| New Technology Impex | Medical Devices | — | no FY data | 39 |
| Doktor Gudsi | Medical Devices | — | no FY data | 39 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.